Andrew D. Leavitt

Professor and Medical Director
Adult Hemophilia Treatment Center, University of California San Francisco, San Francisco, CA, USA

Presentation(s):

• LB 01.3 - Relationship between transgene-produced FVIII and bleeding rates 2 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, July 10, 2022
  3:15 PM – 3:30 PM